BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

728 related articles for article (PubMed ID: 15182338)

  • 1. Safety and efficacy of caspofungin and liposomal amphotericin B, followed by voriconazole in young patients affected by refractory invasive mycosis.
    Cesaro S; Toffolutti T; Messina C; Calore E; Alaggio R; Cusinato R; Pillon M; Zanesco L
    Eur J Haematol; 2004 Jul; 73(1):50-5. PubMed ID: 15182338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rescue therapy with a combination of caspofungin and liposomal amphotericin B or voriconazole in children with haematological malignancy and refractory invasive fungal infections.
    Yilmaz D; Balkan C; Ay Y; Akin M; Karapinar B; Kavakli K
    Mycoses; 2011 May; 54(3):234-42. PubMed ID: 19906090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resolution of disseminated fusariosis in a child with acute leukemia treated with combined antifungal therapy: a case report.
    Vagace JM; Sanz-Rodriguez C; Casado MS; Alonso N; Garcia-Dominguez M; de la Llana FG; Zarallo L; Fajardo M; Bajo R
    BMC Infect Dis; 2007 May; 7():40. PubMed ID: 17493279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caspofungin associated with liposomal amphotericin B or voriconazole for treatment of refractory fungal pneumonia in children with acute leukaemia or undergoing allogeneic bone marrow transplant.
    Castagnola E; Machetti M; Cappelli B; Molinari AC; Morreale G; Dodero P; Tomà P; Faraci M
    Clin Microbiol Infect; 2004 Mar; 10(3):255-7. PubMed ID: 15008948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Successful treatment of neuroaspergillosis in a patient with acute lymphoblastic leukemia: role of surgery, systemic antifungal therapy and intracavitary therapy].
    Ozçelik T; Ozkalemkaş F; Kocaeli H; Altundal Y; Ener B; Ali R; Ozkocaman V; Hakyemez B; Tunali A
    Mikrobiyol Bul; 2009 Jul; 43(3):499-506. PubMed ID: 19795628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caspofungin versus liposomal amphotericin B for empirical therapy.
    Marty FM; Lowry CM
    N Engl J Med; 2005 Jan; 352(4):410-4; author reply 410-4. PubMed ID: 15675093
    [No Abstract]   [Full Text] [Related]  

  • 7. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia.
    Walsh TJ; Teppler H; Donowitz GR; Maertens JA; Baden LR; Dmoszynska A; Cornely OA; Bourque MR; Lupinacci RJ; Sable CA; dePauw BE
    N Engl J Med; 2004 Sep; 351(14):1391-402. PubMed ID: 15459300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin.
    Aliff TB; Maslak PG; Jurcic JG; Heaney ML; Cathcart KN; Sepkowitz KA; Weiss MA
    Cancer; 2003 Feb; 97(4):1025-32. PubMed ID: 12569602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral aspergillosis in the critically ill: two cases of successful medical treatment.
    Ehrmann S; Bastides F; Gissot V; Mercier E; Magro P; Bailly E; Legras A
    Intensive Care Med; 2005 May; 31(5):738-42. PubMed ID: 15782314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic evaluation of targeted treatments of invasive aspergillosis in adult haematopoietic stem cell transplant recipients in the Netherlands: a modelling approach.
    Ament AJ; Hübben MW; Verweij PE; de Groot R; Warris A; Donnelly JP; van 't Wout J; Severens JL
    J Antimicrob Chemother; 2007 Aug; 60(2):385-93. PubMed ID: 17561501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid improvement of disseminated aspergillosis with caspofungin/voriconazole combination in an adult leukemic patient.
    Damaj G; Ivanov V; Le Brigand B; D'incan E; Doglio MF; Bilger K; Faucher C; Vey N; Gastaut JA
    Ann Hematol; 2004 Jun; 83(6):390-3. PubMed ID: 14666380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Voriconazole: new preparation. Invasive aspergillosis: benefits to be confirmed.
    Prescrire Int; 2004 Feb; 13(69):13-6. PubMed ID: 15055210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful elimination of an invasive Aspergillus nidulans lung infection by voriconazole after failure of a combination of caspofungin and liposomal amphotericin B in a boy with chronic granulomatous disease.
    Rösen-Wolff A; Koch A; Friedrich W; Hahn G; Gahr M; Roesler J
    Pediatr Infect Dis J; 2004 Jun; 23(6):584-6. PubMed ID: 15194848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifungal interactions within the triple combination of amphotericin B, caspofungin and voriconazole against Aspergillus species.
    O'Shaughnessy EM; Meletiadis J; Stergiopoulou T; Demchok JP; Walsh TJ
    J Antimicrob Chemother; 2006 Dec; 58(6):1168-76. PubMed ID: 17071635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compassionate use study of caspofungin in children with proven or suspected invasive mycosis or persistent febrile neutropenia.
    Madero L; Sanchez de Toledo J; Castel V; Sevilla J; Gonzalez-Esteban J; Sanz-Rodriguez C
    J Chemother; 2009 Apr; 21(2):229-31. PubMed ID: 19423481
    [No Abstract]   [Full Text] [Related]  

  • 16. [New developments in antifungal therapy: fluconazole, itraconazole, voriconazole, caspofungin].
    van 't Wout JW; Kuijper EJ; Verweij PE; Kullberg BJ
    Ned Tijdschr Geneeskd; 2004 Aug; 148(34):1679-84. PubMed ID: 15453120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disseminated invasive aspergillosis in a patient with acute leukaemia.
    Gottfredsson M; Steingrímsdóttir H
    Acta Biomed; 2006; 77 Suppl 2():10-3. PubMed ID: 16918060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Voriconazole for invasive aspergillosis in oncohematological patients: a single-center pediatric experience.
    Cesaro S; Strugo L; Alaggio R; Cecchetto G; Rigobello L; Pillon M; Cusinato R; Zanesco L
    Support Care Cancer; 2003 Nov; 11(11):722-7. PubMed ID: 13680324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentration-dependent synergy and antagonism within a triple antifungal drug combination against Aspergillus species: analysis by a new response surface model.
    Meletiadis J; Stergiopoulou T; O'Shaughnessy EM; Peter J; Walsh TJ
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2053-64. PubMed ID: 17387150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [symbol: see text]Caspofungin and [symbol: see text]voriconazole for fungal infections.
    Drug Ther Bull; 2004 Jan; 42(1):5-8. PubMed ID: 14768298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.